Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog

Abstract excerpt

Adeno-associated viruses (AAV) have emerged as the lead vector in clinical trials and form the basis for several approved gene therapies for human diseases, mainly owing to their ability to sustain robust and long-term in vivo transgene expression, their amenability to genetic engineering of cargo and capsid, as well as their moderate toxicity and immunogenicity. Still, recent reports of fatalities in a clinical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Animal Virus Infections Studies
• Share to Herpesvirus Infections and Treatments
• Share to Virus-based gene therapy research